从HEROES研究中,急性不补偿性心力衰竭中长时间住院的危险因素
Mateusz Lucki1, Przemysław Mitkowski2, Ewa Lucka3
11st Department of Cardiology, Chair of Cardiology, Poznan University of Medical Sciences, Poznan, Poland. mateusz.lucki@ump.edu.pl.
Scientific reports
|August 9, 2025
概括
由于急性不补偿性心力衰竭 (ADHF) 而长时间住院,与严重的症状,并发病症和特定的治疗方法 (如北上腺素) 有关. 早期识别高风险患者是个性化护理和资源管理的关键.
科学领域:
- 心脏病学 心脏病学
- 临床医学 临床医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 是住院的主要原因.
- 预测ADHF患者的停留时间 (LOS) 对资源分配和患者管理至关重要.
- HEROES项目研究心力衰竭的风险因素和患者分层.
研究的目的:
- 确定ADHF患者长期住院 (LOS>8天) 相关的临床,实验室,功能和治疗相关因素.
- 在这个人群中区分短期和长期住院的预测因素.
- 为个性化管理ADHF患者的策略提供信息.
主要方法:
- 对562名因ADHF入院的白人患者的分析,按LOS分类 (≤8天与>8天).
- 收集社会人口统计,临床,实验室,成像,治疗和患者报告的健康状况 (KCCQ-12) 数据.
- 多变量后勤回归用于识别长时间住院的独立预测因素.
主要成果:
- 患有较长时间LOS的患者表现出更高的NYHA类,更大的并发症负担,更长时间的密集心脏护理单位 (ICCU) 停留,以及更高的住院死亡率.
- 较高的NT-proBNP,前素和肌素,以及较低的血红蛋白,血红素和水平,与较长的LOS有关.
- 长时间住院的独立预测因素包括诺亚上腺素和多巴胺治疗,以及口服铁疗法. 保护因素包括较高的KCCQ-12得分,入院时较高的静脉压,以及之前使用的他类药物.
结论:
- 在ADHF中长时间住院与更严重的心力衰竭症状,更高的并发症负载,功能/实验室参数受损和更长时间的ICCU停留有关.
- 上腺素,多巴胺和口服铁疗法是延长住院时间的预测因素.
- 较高的KCCQ-12分数,入院时的缩血压和先前的他类药物使用与减少的LOS有关,这表明潜在的治疗点.
更多相关视频
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.2K
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
3.0K
相关概念视频
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:29Heart Failure II: Pathophysiology
41
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
41
01:26Heart Failure III: Clinical Manifestations
45
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
45
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
01:27Heart Failure I: Introduction
55
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27